Department of Public Health, Texas Tech University Health Sciences Center, Lubbock, TX.
Division of Cardiology, Johns Hopkins University, Baltimore, MD.
Menopause. 2020 Jun;27(6):658-667. doi: 10.1097/GME.0000000000001522.
To test the hypothesis that a family history of premature myocardial infarction (FHPMI) will modify the associations between bilateral salpingo-oophorectomy (BSO) and mortality due to heart disease (HD), cardiovascular disease (CVD), or all-cause mortality with stronger associations observed for BSO occurring before 45 years.
We analyzed data from 2,763 postmenopausal women aged 40 years or older who participated in the National Health and Nutrition Examination Survey (1988-1994) and were followed through December 31, 2015. Cox regression was used to estimate adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for mortality outcomes (HD, CVD, and all-cause).
At baseline, the average age was 62 years. There were 610 women with BSO, 338 women with FHPMI, and 95 women with both BSO and FHPMI. During a median follow-up of 22 years, 1,713 deaths occurred of which 395 and 542 were attributed to HD and CVD, respectively. In models adjusting for CVD risk factors and hormone therapy use, HD mortality was greater among women with both BSO and FHPMI compared to those without either of these conditions (HR: 2.88, 95% CI: 1.72-4.82, PInteraction = 0.016). HD mortality was higher among women with FHPMI and BSO at an earlier age (<45 y: HR: 4.32, 95% CI: 1.95-9.50 vs ≥45 y: HR: 1.60, 95% CI: 0.63-4.09). Similar observations were seen for CVD and all-cause mortality.
In this study, the risk of HD, CVD, and all-cause mortality in women with BSO was modified by an FHPMI with the risk limited to women undergoing BSO at younger ages.
检验以下假设,即早发性心肌梗死家族史(FHPMI)会改变双侧输卵管卵巢切除术(BSO)与心脏病(HD)、心血管疾病(CVD)或全因死亡率之间的关联,在 45 岁之前进行 BSO 的患者中观察到更强的关联。
我们分析了 2763 名年龄在 40 岁及以上的绝经后女性的数据,这些女性参加了国家健康和营养调查(1988-1994 年),并随访至 2015 年 12 月 31 日。使用 Cox 回归估计死亡率结局(HD、CVD 和全因)的调整后的危险比(HR)和 95%置信区间(CI)。
在基线时,平均年龄为 62 岁。有 610 名女性接受了 BSO,338 名女性有 FHPMI,95 名女性同时有 BSO 和 FHPMI。在中位随访 22 年期间,有 1713 人死亡,其中 395 人归因于 HD,542 人归因于 CVD。在调整 CVD 风险因素和激素治疗使用的模型中,与没有这些情况的女性相比,同时有 BSO 和 FHPMI 的女性的 HD 死亡率更高(HR:2.88,95%CI:1.72-4.82,P 交互=0.016)。在年龄较小的女性(<45 岁:HR:4.32,95%CI:1.95-9.50 vs ≥45 岁:HR:1.60,95%CI:0.63-4.09)中,FHPMI 和 BSO 患者的 HD 死亡率更高。对于 CVD 和全因死亡率也观察到了类似的结果。
在这项研究中,BSO 女性的 HD、CVD 和全因死亡率风险由 FHPMI 改变,风险仅限于年龄较小的女性进行 BSO。